Cytokinetics (CYTK) Notes Payables (2011 - 2026)

Cytokinetics (CYTK) has reported Notes Payables for 3 consecutive years, with $29.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Notes Payables rose 152.99% year-over-year to $29.6 million; the TTM figure through Mar 2026 stood at $29.6 million (up 152.99% YoY), while the FY2025 annual figure was $31.1 million, up 175.22% from the prior year.
• Notes Payables slipped to $29.6 million in Q1 2026 per CYTK's latest filing, from $31.1 million in the prior quarter.
• Across five years, Notes Payables topped out at $31.1 million in Q4 2025 and bottomed at $11.3 million in Q4 2024.
• Historically, Notes Payables has averaged $18.0 million across 3 years, with a median of $15.0 million in 2024.
• On a YoY basis, Notes Payables climbed as much as 175.22% in 2025 and fell as far as 33.33% in 2025.
• Cytokinetics' Notes Payables stood at $11.3 million in 2024, then surged by 175.22% to $31.1 million in 2025, then declined by 4.82% to $29.6 million in 2026.
• Business Quant data shows CYTK's Notes Payables at $29.6 million in Q1 2026, $31.1 million in Q4 2025, and $16.9 million in Q3 2025.